About: Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis   Goto Sponge  NotDistinct  Permalink

An Entity of Type : owl:Thing, within Data Space : data.idref.fr associated with source document(s)

AttributesValues
Author
Bibliographic Citation
  • Bonneau Claire, Paintaud Gilles, Trédan Olivier, Dubot Coraline, Desvignes Celine, Dieras Véronique, Taillibert Sophie, Tresca Patricia, Turbiez Isabelle, Li Jacques, Passot Christophe, Mefti Fawzia, Mouret-Fourme Emmanuelle, Le Rhun Emilie, Gutierrez Maya. Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis. European Journal of Cancer, Elsevier, 2018, 95, pp.75-84. ⟨10.1016/j.ejca.2018.02.032⟩
  • Bonneau Claire, Paintaud Gilles, Trédan Olivier, Dubot Coraline, Desvignes Celine, Dieras Véronique, Taillibert Sophie, Tresca Patricia, Turbiez Isabelle, Li Jacques, Passot Christophe, Mefti Fawzia, Mouret-Fourme Emmanuelle, Le Rhun Emilie, Gutierrez Maya. Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis. European Journal of Cancer, 2018, 95, pp.75-84. ⟨10.1016/j.ejca.2018.02.032⟩
Title
  • Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis
dc:date
  • 2018
Digital Object Identifier (DOI)
  • 10.1016/j.ejca.2018.02.032
Faceted Search & Find service v1.13.91 as of Aug 16 2018


Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software